Griffith Hack principal Karen Sinclair recently joined host Lisa Leong on the From Idea to Intellectual Property podcast series to discuss the emerging trends and key issues in the area of synthetic biology.
About the episode
Scientists commenced mapping the human genome in 1990, and while we’ve come a long way since then, we’re really only just starting out on the journey of using genetic material to solve problems in medicine, manufacturing and agriculture.
However, as Griffith Hack Principal Karen Sinclair explains to host Lisa Leong, since mapping genetic material went mainstream getting granted patent protection for genetic sequences has become more complex. The advent of synthetic biology has enabled a great leap forward; enabling scientists to redesign sequences to produce replicas or adjusted versions of a biological outcome. And, importantly, to enable the “novelty” and “inventiveness” tests of patent law to be fulfilled.
The technology comes with its fair share of scientific and ethical conundrums, and Karen explains the vital role of IP both in protecting the investment of the people working in this ground-breaking field, and ensuring ethical boundaries aren’t breached.
Listen to the episode via the player below, or view the full series over at Podbean:
About the podcast series
From Idea to Intellectual Property explores today’s big ideas through the lens of the intellectual property specialists who work with inventors and innovators to bring their ideas to reality.
Hosted by broadcaster, author, and former IP lawyer Lisa Leong, each episode is a conversation with an expert from IPH Limited, Asia Pacific’s leading intellectual property services group, about a global trend or an industry with global impact. Guests will share first-hand insights on what’s involved in turning an idea into a commercial reality, in particular how to protect an inventors’ IP, and what current trends can tell us about what we can expect from future innovation.
